[1]
2023. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Medical Weekly. 153, 9 (Sep. 2023), s3441 . DOI:https://doi.org/10.57187/s.3441.